The neurodevelopmental and facial phenotype in individuals with a TRIP12 variant.


Journal

European journal of human genetics : EJHG
ISSN: 1476-5438
Titre abrégé: Eur J Hum Genet
Pays: England
ID NLM: 9302235

Informations de publication

Date de publication:
04 2023
Historique:
received: 07 07 2022
accepted: 27 01 2023
revised: 22 11 2022
pmc-release: 01 04 2024
medline: 28 4 2023
pubmed: 7 2 2023
entrez: 6 2 2023
Statut: ppublish

Résumé

Haploinsufficiency of TRIP12 causes a neurodevelopmental disorder characterized by intellectual disability associated with epilepsy, autism spectrum disorder and dysmorphic features, also named Clark-Baraitser syndrome. Only a limited number of cases have been reported to date. We aimed to further delineate the TRIP12-associated phenotype and objectify characteristic facial traits through GestaltMatcher image analysis based on deep-learning algorithms in order to establish a TRIP12 gestalt. 38 individuals between 3 and 66 years (F = 20, M = 18) - 1 previously published and 37 novel individuals - were recruited through an ERN ITHACA call for collaboration. 35 TRIP12 variants were identified, including frameshift (n = 15) and nonsense (n = 6) variants, as well as missense (n = 5) and splice (n = 3) variants, intragenic deletions (n = 4) and two multigene deletions disrupting TRIP12. Though variable in severity, global developmental delay was noted in all individuals, with language deficit most pronounced. About half showed autistic features and susceptibility to obesity seemed inherent to this disorder. A more severe expression was noted in individuals with a missense variant. Facial analysis showed a clear gestalt including deep-set eyes with narrow palpebral fissures and fullness of the upper eyelids, downturned corners of the mouth and large, often low-set ears with prominent earlobes. We report the largest cohort to date of individuals with TRIP12 variants, further delineating the associated phenotype and introducing a facial gestalt. These findings will improve future counseling and patient guidance.

Identifiants

pubmed: 36747006
doi: 10.1038/s41431-023-01307-x
pii: 10.1038/s41431-023-01307-x
pmc: PMC10133310
doi:

Substances chimiques

TRIP12 protein, human EC 2.3.2.26
Carrier Proteins 0
Ubiquitin-Protein Ligases EC 2.3.2.27

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

461-468

Subventions

Organisme : NHGRI NIH HHS
ID : UM1 HG008900
Pays : United States

Informations de copyright

© 2023. The Author(s), under exclusive licence to European Society of Human Genetics.

Références

Am J Hum Genet. 2009 Apr;84(4):524-33
pubmed: 19344873
Am J Med Genet A. 2020 Jul;182(7):1801-1806
pubmed: 32424948
Nat Genet. 2022 Mar;54(3):349-357
pubmed: 35145301
Nucleic Acids Res. 1987 Sep 11;15(17):7155-74
pubmed: 3658675
Am J Med Genet. 1987 Jan;26(1):13-5
pubmed: 3812552
Genet Med. 2015 May;17(5):405-24
pubmed: 25741868
PLoS One. 2011;6(10):e25871
pubmed: 22028794
Hum Genet. 2017 Feb;136(2):179-192
pubmed: 27848077
Nature. 2014 Nov 13;515(7526):216-21
pubmed: 25363768
Am J Med Genet A. 2020 Mar;182(3):595-596
pubmed: 31814248
Nat Commun. 2014 Nov 24;5:5595
pubmed: 25418537
J Comput Biol. 2004;11(2-3):377-94
pubmed: 15285897
Hum Genet. 2017 Apr;136(4):377-386
pubmed: 28251352
J Clin Endocrinol Metab. 2017 Mar 01;102(3):709-757
pubmed: 28359099
Front Genet. 2018 Feb 14;9:29
pubmed: 29491882
Int J Mol Sci. 2020 Nov 12;21(22):
pubmed: 33198194
J Comput Biol. 1997 Fall;4(3):311-23
pubmed: 9278062
Int J Mol Sci. 2022 Nov 08;23(22):
pubmed: 36430143
Nat Neurosci. 2016 Sep;19(9):1194-6
pubmed: 27479843

Auteurs

Mio Aerden (M)

Center for Human Genetics, University Hospitals Leuven, KU Leuven, Leuven, Belgium. mio.aerden@uzleuven.be.

Anne-Sophie Denommé-Pichon (AS)

Unité Fonctionnelle Innovation en Diagnostic génomique des maladies rares, FHU-TRANSLAD, CHU Dijon Bourgogne, Dijon, France.
UMR1231 GAD, Inserm - Université Bourgogne-Franche Comté, Dijon, France.

Dominique Bonneau (D)

Department of Biochemistry and Genetics, Angers University Hospital and UMR CNRS 6015-INSERM 1083, Angers, France.

Ange-Line Bruel (AL)

Unité Fonctionnelle Innovation en Diagnostic génomique des maladies rares, FHU-TRANSLAD, CHU Dijon Bourgogne, Dijon, France.
UMR1231 GAD, Inserm - Université Bourgogne-Franche Comté, Dijon, France.

Julian Delanne (J)

UMR1231 GAD, Inserm - Université Bourgogne-Franche Comté, Dijon, France.
Centre de Référence Anomalies du Développement et Syndromes Malformatifs, FHU TRANSLAD, Hôpital d'Enfants, CHU Dijon, Dijon, France.

Bénédicte Gérard (B)

Laboratoire de Diagnostic Génétique, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.

Benoît Mazel (B)

UMR1231 GAD, Inserm - Université Bourgogne-Franche Comté, Dijon, France.
Centre de Référence Anomalies du Développement et Syndromes Malformatifs, FHU TRANSLAD, Hôpital d'Enfants, CHU Dijon, Dijon, France.

Christophe Philippe (C)

Unité Fonctionnelle Innovation en Diagnostic génomique des maladies rares, FHU-TRANSLAD, CHU Dijon Bourgogne, Dijon, France.
UMR1231 GAD, Inserm - Université Bourgogne-Franche Comté, Dijon, France.

Lucile Pinson (L)

Service de génétique - Centre de Référence Anomalies du Développement CLAD Sud Est, Groupement Hospitalier Est, Hospices Civils de Lyon, Bron, France.

Clément Prouteau (C)

Department of Biochemistry and Genetics, Angers University Hospital and UMR CNRS 6015-INSERM 1083, Angers, France.

Audrey Putoux (A)

Centre de Référence Anomalies du Développement et Syndromes Malformatifs Centre Est, Hospices Civils de Lyon, Lyon, France.

Frédéric Tran Mau-Them (F)

Unité Fonctionnelle Innovation en Diagnostic génomique des maladies rares, FHU-TRANSLAD, CHU Dijon Bourgogne, Dijon, France.
UMR1231 GAD, Inserm - Université Bourgogne-Franche Comté, Dijon, France.

Éléonore Viora-Dupont (É)

UMR1231 GAD, Inserm - Université Bourgogne-Franche Comté, Dijon, France.
Centre de Référence Anomalies du Développement et Syndromes Malformatifs, FHU TRANSLAD, Hôpital d'Enfants, CHU Dijon, Dijon, France.

Antonio Vitobello (A)

Unité Fonctionnelle Innovation en Diagnostic génomique des maladies rares, FHU-TRANSLAD, CHU Dijon Bourgogne, Dijon, France.
UMR1231 GAD, Inserm - Université Bourgogne-Franche Comté, Dijon, France.

Alban Ziegler (A)

Department of Biochemistry and Genetics, Angers University Hospital and UMR CNRS 6015-INSERM 1083, Angers, France.

Amélie Piton (A)

Hôpitaux Universitaires de Strasbourg, Laboratoire de Diagnostic Génétique, Strasbourg, France.

Bertrand Isidor (B)

Service de Genetique Medicale, CHU de Nantes & Inserm, CNRS, Universite de Nantes, l'institut du thorax, Nantes, France.

Christine Francannet (C)

Service de Genetique Medicale, CHU de Clermont-Ferrand, Clermont-Ferrand, France.

Pierre-Yves Maillard (PY)

Service de Genetique Medicale, IGMA, Hopitaux Universitaires de Strasbourg, Strasbourg, France.

Sophie Julia (S)

Service de Génétique Clinique, CHU Toulouse, Toulouse, France.

Anais Philippe (A)

Service de Genetique Medicale, IGMA, Hopitaux Universitaires de Strasbourg, Strasbourg, France.

Elise Schaefer (E)

Service de Genetique Medicale, IGMA, Hopitaux Universitaires de Strasbourg, Strasbourg, France.

Saskia Koene (S)

Department of Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands.

Claudia Ruivenkamp (C)

Department of Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands.

Mariette Hoffer (M)

Department of Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands.

Eric Legius (E)

Center for Human Genetics, University Hospitals Leuven, KU Leuven, Leuven, Belgium.

Miel Theunis (M)

Center for Human Genetics, University Hospitals Leuven, KU Leuven, Leuven, Belgium.

Boris Keren (B)

Genetic Department, Pitié-Salpêtrière Hospital, AP-HP.Sorbonne Université, Paris, France.

Julien Buratti (J)

Genetic Department, Pitié-Salpêtrière Hospital, AP-HP.Sorbonne Université, Paris, France.

Perrine Charles (P)

Genetic Department, Pitié-Salpêtrière Hospital, AP-HP.Sorbonne Université, Paris, France.

Thomas Courtin (T)

Genetic Department, Pitié-Salpêtrière Hospital, AP-HP.Sorbonne Université, Paris, France.

Mala Misra-Isrie (M)

Department of Human Genetics, Amsterdam University Medical Centers, Location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.

Mieke van Haelst (M)

Department of Human Genetics, Amsterdam University Medical Centers, Location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.

Quinten Waisfisz (Q)

Department of Human Genetics, Amsterdam University Medical Centers, Location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.

Dagmar Wieczorek (D)

Heinrich-Heine-Universität, Institut für Humangenetik, Düsseldorf, Germany.

Ariane Schmetz (A)

Heinrich-Heine-Universität, Institut für Humangenetik, Düsseldorf, Germany.

Theresia Herget (T)

Institute of Human Genetics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Fanny Kortüm (F)

Institute of Human Genetics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Jasmin Lisfeld (J)

Institute of Human Genetics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

François-Guillaume Debray (FG)

Centre Hospitalier Universitaire de Liège, Center of Human Genetics, Liège, Belgium.

Nuria C Bramswig (NC)

Heinrich-Heine-Universität, Institut für Humangenetik, Düsseldorf, Germany.

Isis Atallah (I)

Lausanne University Hospital, Division of Genetic Medicine, Lausanne, Switzerland.

Heidi Fodstad (H)

Lausanne University Hospital, Division of Genetic Medicine, Lausanne, Switzerland.

Guillaume Jouret (G)

National Center of Genetics (NCG), Laboratoire national de santé (LNS), Dudelange, Luxembourg.

Berta Almoguera (B)

Fundación Jiménez Díaz Hospital, Department of Genetics and Genomics, Madrid, Spain.

Saoud Tahsin-Swafiri (S)

Fundación Jiménez Díaz Hospital, Department of Genetics and Genomics, Madrid, Spain.

Fernando Santos-Simarro (F)

Institute of Medical and Molecular Genetics (INGEMM), Hospital Universitario La Paz, IdiPAZ, CIBERER, ISCIII, Madrid, Spain.
Molecular Diagnostics and Clinical Genetics Unit (UDMGC), Hospital Universitari Son Espses, IdISBa, Palma, Spain.

Maria Palomares-Bralo (M)

Institute of Medical and Molecular Genetics (INGEMM), Hospital Universitario La Paz, IdiPAZ, CIBERER, ISCIII, Madrid, Spain.

Vanesa López-González (V)

Hospital Clínico Universitario Virgen de la Arrixaca, IMIB-Arrixaca, Sección de Genética Médica, Servicio de Pediatría, Murcia, Spain.

Maria Kibaek (M)

Pediatric Department, Odense University Hospital, Odense, Denmark.

Pernille M Tørring (PM)

Department of Clinical Genetics, Odense University Hospital, Odense, Denmark.

Alessandra Renieri (A)

Medical Genetics, University of Siena, Siena, Italy.
Med Biotech Hub and Competence Center, Department of Medical Biotechnologies, University of Siena, Siena, Italy.
Genetica Medica, Azienda Ospedaliera Universitaria Senese, Siena, Italy.

Lucia Pia Bruno (LP)

Medical Genetics, University of Siena, Siena, Italy.
Med Biotech Hub and Competence Center, Department of Medical Biotechnologies, University of Siena, Siena, Italy.

Katrin Õunap (K)

Tartu University Hospital, Genetic and Personalized Medicine Clinic, Department of Clinical Genetics, Tartu, Estonia.
University of Tartu, Institute of Clinical Medicine, Tartu, Estonia.

Monica Wojcik (M)

Department of Pediatrics, Boston Children's Hospital, Divisions of Newborn Medicine and Genetics and Genomics, Boston, MA, USA.
The Broad Institute of MIT and Harvard, Cambridge, MA, USA.

Tzung-Chien Hsieh (TC)

Institute for Genomic Statistics and Bioinformatics, University Hospital Bonn, Rheinische Friedrich-Wilhelms-Universität Bonn, Bonn, Germany.

Peter Krawitz (P)

Institute for Genomic Statistics and Bioinformatics, University Hospital Bonn, Rheinische Friedrich-Wilhelms-Universität Bonn, Bonn, Germany.

Hilde Van Esch (H)

Center for Human Genetics, University Hospitals Leuven, KU Leuven, Leuven, Belgium. hilde.vanesch@uzleuven.be.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH